by Cell cryopreservation refers to the process of preserving cells in a frozen state over extended periods of time. Cryopreservation is widely used by research laboratories, biobanks, and fertility clinics to store biological materials such as stem cells, sperm, and ova for future use in research or medical procedures. The growing applications of regenerative medicine and stem cell therapy have increased the demand for preservation of various cell types. Cell lines are also frozen for research purposes in pharmaceutical and biotechnology industries. The global cell cryopreservation market allows scientists and clinicians to preserve viable cells and tissues for future experiments or therapeutic applications.
It is estimated to be valued at US$ 228.8 Mn in 2023 and is expected to exhibit a CAGR of 5.7% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
The cell cryopreservation process involves cooling the cells at a very slow, controlled rate to -80°C–-196°C, usually with the use of cryoprotective substances such as dimethyl sulphoxide (DMSO) that prevent the formation of ice crystals which can damage or kill cells during freezing. Cryopreservation allows long-term storage of biological samples without extensive sample deterioration. It maintains sample viability for future experiments instead of constant replenishment. The benefits of cryopreservation also include standardized protocols for preservation of a wide range of cell types from various adult and embryonic sources. It facilitates collaborative research through sharing of biological resources between laboratories located in different geographical regions.
Market key trends:
The rise of regenerative medicine is a major trend driving the Global Cell Cryopreservation Market Size. Regenerative therapies rely on preservation of stem cells from sources such as bone marrow, adipose tissue, and umbilical cord blood. These cells are frozen and banked for future therapeutic use in treatments for degenerative diseases. The increasing success of stem cell therapies in clinical trials is raising investments in building biobanks for storage of stem cell units. Growing awareness about fertility preservation is also boosting the demand for cryopreservation of reproductive cells and tissues. Another key trend is customization of cryopreservation protocols according to cell type to maximize post-thaw viability for specific research and clinical applications.
Porter’s Analysis
Threat of new entrants: Low threat as this market requires significant R&D investments and compliance with stringent regulations.
Bargaining power of buyers: Moderate power as Cryo preservation is required by research institutes and pharma companies. There exist alternatives like freezing cells.
Bargaining power of suppliers: Low as suppliers have been established over years and manufacturers require expertise in cell biology and cryopreservation techniques.
Threat of new substitutes: Low threat as alternatives lack efficacy and accuracy for long-term preservation of cells required for research.
Competitive rivalry: High as there exist global players catering to this market. Competition drives innovation in products and technologies.
Key Takeaways
The global cell cryopreservation market is expected to witness high growth over the forecast period driven by increasing prevalence of chronic diseases and growth in pharmaceutical and biotech industries. The global cell cryopreservation market is estimated to be valued at US$ 228.8 Mn in 2023 and is expected to exhibit a CAGR of 5.7% over the forecast period 2023 to 2030.
North America dominates the market currently due to presence of key market players and advanced healthcare infrastructure. Factors like growing R&D investments, rising biobanking activities, stringent regulations, and focus on personalized medicine are fueling the market in the region.
Key players operating in the cell cryopreservation market are BASF, DSM, Kemin Industries, Naturex, Synthite Industries. Cell cryopreservation finds widespread usage in stem cell research, IVF treatments and biobanking. It helps preserve cell viability and function for future therapeutic applications and research works. Rising stem cell therapy and regenerative medicine research also contributes to market growth.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
